Cargando…

Identification of Survival-Associated Alternative Splicing Signatures in Lung Squamous Cell Carcinoma

Purpose: Alternative splicing (AS) is a post-transcriptional process that plays a significant role in enhancing the diversity of transcription and protein. Accumulating evidences have demonstrated that dysregulation of AS is associated with oncogenic processes. However, AS signature specifically in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yang, Jia, Wenxiao, Li, Ji, Zhu, Hui, Yu, Jinming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7561379/ https://www.ncbi.nlm.nih.gov/pubmed/33117720 http://dx.doi.org/10.3389/fonc.2020.587343

Ejemplares similares

Systematic Analysis of Survival-Associated Alternative Splicing Signatures in Thyroid Carcinoma
por: Han, Baoai, et al.
Publicado: (2021)

Comprehensive Analysis of Prognostic Alternative Splicing Signatures in Oral Squamous Cell Carcinoma
por: Cao, Ruoyan, et al.
Publicado: (2020)

Development of alternative splicing signature in lung squamous cell carcinoma
por: Yan, Jia-qing, et al.
Publicado: (2021)

Emerging roles of alternative RNA splicing in oral squamous cell carcinoma
por: Liu, Miaomiao, et al.
Publicado: (2022)

Prognostic Signatures of Alternative Splicing Events in Esophageal Carcinoma Based on TCGA Splice-Seq Data
por: Ye, Ping, et al.
Publicado: (2021)

Identification and Validation of a Four-Gene Ferroptosis Signature for Predicting Overall Survival of Lung Squamous Cell Carcinoma
por: Wang, Qi, et al.
Publicado: (2022)

Survival-Associated Alternative Splicing Events in Pan-Renal Cell Carcinoma
por: Jia, Keren, et al.
Publicado: (2019)

Identification and Validation of a Prognostic Immune-Related Alternative Splicing Events Signature for Glioma
por: Wang, Minjie, et al.
Publicado: (2021)

Identification and Validation of Novel Immune-Related Alternative Splicing Signatures as a Prognostic Model for Colon Cancer
por: Liu, Yunze, et al.
Publicado: (2022)

A Prediction Model Using Alternative Splicing Events and the Immune Microenvironment Signature in Lung Adenocarcinoma
por: Zhu, Liping, et al.
Publicado: (2021)

Genome-Wide Profiling of Prognostic Alternative Splicing Signature in Colorectal Cancer
por: Zong, Zhen, et al.
Publicado: (2018)

Identification of survival-associated alternative splicing events and signatures in adrenocortical carcinoma based on TCGA SpliceSeq data
por: Xu, Ning, et al.
Publicado: (2020)

Genome-Wide Analyses of Prognostic and Therapeutic Alternative Splicing Signatures in Bladder Urothelial Carcinoma
por: Fan, Zhongru, et al.
Publicado: (2021)

Identification of Mutator-Derived Alternative Splicing Signatures of Genomic Instability for Improving the Clinical Outcome of Cholangiocarcinoma
por: Lin, Zijing, et al.
Publicado: (2021)

Downregulation of lncRNA XR_429159.1 Linked to Brain Metastasis in Patients With Limited-Stage Small-Cell Lung Cancer
por: Li, Ji, et al.
Publicado: (2021)

Identification of Prognostic Alternative Splicing Signature in Breast Carcinoma
por: Zhang, Dong, et al.
Publicado: (2019)

Systemic Analysis of RNA Alternative Splicing Signals Related to the Prognosis for Head and Neck Squamous Cell Carcinoma
por: Li, Zhexuan, et al.
Publicado: (2020)

Screening and Identification of Survival-Associated Splicing Factors in Lung Squamous Cell Carcinoma
por: Chen, Min, et al.
Publicado: (2022)

Comprehensive Analysis of Prognostic Alternative Splicing Signature Reveals Recurrence Predictor for Papillary Thyroid Cancer
por: Liu, Mian, et al.
Publicado: (2021)

Development of a Prognostic Alternative Splicing Signature Associated With Tumor Microenvironment Immune Profiles in Lung Adenocarcinoma
por: Bao, Guangyao, et al.
Publicado: (2022)

Identification and validation of an alternative splicing-based prognostic signature for head and neck squamous cell carcinoma
por: Zhao, Xinyuan, et al.
Publicado: (2020)

Genome-Wide Profiling Reveals the Landscape of Prognostic Alternative Splicing Signatures in Pancreatic Ductal Adenocarcinoma
por: Yang, Chengkun, et al.
Publicado: (2019)

Identification of survival-related alternative splicing signatures in acute myeloid leukemia
por: Zhang, Biyu, et al.
Publicado: (2021)

Identification of Hypoxia-Related Molecular Classification and Associated Gene Signature in Oral Squamous Cell Carcinoma
por: Li, Chen, et al.
Publicado: (2021)

Novel, alternative splicing signature to detect lymph node metastasis in prostate adenocarcinoma with machine learning
por: Xie, Ping, et al.
Publicado: (2023)

Identification and Validation of an Apoptosis-Related Gene Prognostic Signature for Oral Squamous Cell Carcinoma
por: Wang, Shuqin, et al.
Publicado: (2022)

Identification and validation of a novel necroptosis-related prognostic signature in cervical squamous cell carcinoma and endocervical adenocarcinoma
por: Zhang, Weiyu, et al.
Publicado: (2022)

Systematic Profiling of Alternative mRNA Splicing Signature for Predicting Glioblastoma Prognosis
por: Chen, Xueran, et al.
Publicado: (2019)

Development and Validation of Autophagy-Related Gene Signature and Nomogram for Predicting Survival in Oral Squamous Cell Carcinoma
por: Hou, Chen, et al.
Publicado: (2020)

Survival-associated alternative splicing signatures in non-small cell lung cancer
por: Zhao, Deze, et al.
Publicado: (2020)

Identification of RNA Modification-Associated Alternative Splicing Signature as an Independent Factor in Head and Neck Squamous Cell Carcinoma
por: Liu, Jie, et al.
Publicado: (2022)

Alternative Splicing-Based Differences Between Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: Genes, Immune Microenvironment, and Survival Prognosis
por: Luo, Dingan, et al.
Publicado: (2021)

The landscape of alternative splicing in cervical squamous cell carcinoma
por: Guo, Peng, et al.
Publicado: (2014)

Identification of Survival-Associated Gene Signature in Lung Cancer Coexisting With COPD
por: Miao, Ti-wei, et al.
Publicado: (2021)

Prognostic Alternative Splicing Signatures in Esophageal Carcinoma
por: Dlamini, Zodwa, et al.
Publicado: (2021)

Autophagy-Related Three-Gene Prognostic Signature for Predicting Survival in Esophageal Squamous Cell Carcinoma
por: Cui, Heyang, et al.
Publicado: (2021)

Identification of prognostic and metastasis-related alternative splicing signatures in hepatocellular carcinoma
por: Huang, Runzhi, et al.
Publicado: (2020)

Identification of Tumor Microenvironment-Related Alternative Splicing Events to Predict the Prognosis of Endometrial Cancer
por: Liu, Xuan, et al.
Publicado: (2021)

Alternative splicing event associated with immunological features in bladder cancer
por: Yu, Xinbo, et al.
Publicado: (2023)

Profiles of prognostic alternative splicing signature in hepatocellular carcinoma
por: Wu, Fangming, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5mtcr7vgp669ekgq982uhpm898